ChemFaces is a professional high-purity natural products manufacturer.
Product Intended Use
1. Reference standards
2. Pharmacological research
Citing Use of our Products
How to Order
Orders via your E-mail:
1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Sent to Email: firstname.lastname@example.org
Order & Inquiry & Tech Support
Address: No. 83, CheCheng Rd., WETDZ, Wuhan, Hubei 430056, PRC
Delivery & Payment method
1. Usually delivery time: Next day delivery by 9:00 a.m. Order now
2. We accept: Wire transfer & Credit card & Paypal & Western Union
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
|Size /Price /Stock
||10 mM * 1 mL in DMSO / $11.8 / In-stock||Other Packaging
||*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
More articles cited ChemFaces products.
Evid Based Complement Alternat Me...2018...Plant Cell Tiss Org2017, 479-486Molecules2022, 27(3),1140.Antiviral Res.2013, 98(3):386-93International Food Research Journ...2018...J Agric Food Chem....2021...Plant Sci.2021, 313:111069.J Korean Society of Food Science ...2021...
Enzyme Microb Technol....2022...Nat Prod Commun.2014, 9(5):679-82Phytomedicine.2019, 55:229-237Nutr Res Pract.2020, 14(5):478-489.Free Radic Biol Med.2021, 166:104-115.Toxicol In Vitro.2018, 52:94-105J Bone Miner Res.2017, 32(12):2415-2430In Vitro Cellular & Developmental...2021...
Genes Genomics.2020, 10.1007Agronomy2020, 10(10),1489Int J Mol Sci.2021, 22(21):11447.Pharmacognosy Journal...2019...Int J Mol Sci.2019, 20(21):E5488Molecules.2020, 25(7):1625.Evid Based Complement Alternat Me...2020...
Our products had been exported to the following research institutions and universities, And still growing.
Deutsches Krebsforschungszentrum (Germany)Kazusa DNA Research Institute (Japan)Istanbul University (Turkey)Florida A&M University (USA)
Institute of Chinese Materia Me... (China)Colorado State University (USA)Guangzhou Institutes of Biomedi... (China)University of Vigo (Spain)
University of Melbourne (Australia)China Medical University (Taiwan)Kitasato University (Japan)
Inquire / Order:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Molecules.2019, 24(17):E3127Food Engineering Progress2019, 23(3)209-216Front Cell Dev Biol.2021, 9:638174. Korean Journal of Pharmacognosy2018, 49(1):76-83Internoational J of Toxicology2020, 10.1177.Toxicol Res.2019, 35(4):371-387Antioxidants (Basel).2021, 10(3):379.Antioxidants (Basel).2020, 9(7):581.Int J Mol Sci.2018, 19(9):E2825Microorganisms.2021, 9(12):2514.
Related Screening Libraries
||Bakuchiol possesses anti-tumor, cytotoxic, anti-bacterial , and anti-helmenthic properties, it shows DNA polymerase1 inhibiting activity. Bakuchiol has great potential for use in food additives and mouthwash for preventing and treating dental caries. |
||Antifection | Nrf2 | MMP(e.g.TIMP) | UGT1A1|
|Zhong Yao Cai. 2014 Apr;37(4):632-5. |
|Regulative effect of bakuchiol on ESF-1 cells anti-aging gene[Pubmed: 25345139]|
|To explore the mechanism of Bakuchiol on anti-aging gene mRNA expression level of human skin fibroblasts (ESF-1).
METHODS AND RESULTS:
The potential of cell proliferation which was divided into blank group,positive control estradiol group, and Bakuchiol high, medium and low dose groups was detected by MTT. The expression levels of Col I, Col III, TIMP-1, TIMP-2 and MMP-1 mRNA were detected with RT-PCR.
ESF-1 vitality and the expression levels of Col I, Col III, TIMP-1 and TIMP-2 mRNA were significantly increased by Bakuchiol and E2. However, the expression of MMP-1 mRNA was reduced by Bakuchiol and E2.
The Bakuchiol can enhance ESF-1 cell activity, promote collagen and matrix metalloproteinase inhibitors mRNA expression level and inhibit mRNA expression of matrix metalloproteinases in order to postpone skin aging.
|Phytomedicine. 2014 Jun 15;21(7):942-5. |
|Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model.[Pubmed: 24703327]|
|Bakuchiol was an active antifungal compound isolated from Psoraleae Fructus by means of bioassay-guided fractionation in our previous study. |
METHODS AND RESULTS:
The present work aimed to investigate the underlying mechanisms and the therapeutic effect of Bakuchiol in Trichophyton mentagrophytes-induced tinea pedis. After exposure to Bakuchiol at 0.25-fold, 0.5-fold and 1-fold of minimum inhibitory concentration (MIC) (3.91 μg/ml) for 24h, the fungal conidia of T. mentagrophytes demonstrated a significant dose-dependent increase in membrane permeability. Moreover, Bakuchiol at 1-fold MIC elicited a 187% elevation in reactive oxygen species (ROS) level in fungal cells after a 3-h incubation. However, Bakuchiol did not induce DNA fragmentation. In a guinea pig model of tinea pedis, Bakuchiol at 1%, 5% or 10% (w/w) concentration in aqueous cream could significantly reduce the fungal burden of infected feet (p<0.01-0.05).
In conclusion, this is the first report to demonstrate that Bakuchiol is effective in relieving tinea pedis and in inhibiting the growth of the dermatophyte T. mentagrophytes by increasing fungal membrane permeability and ROS generation, but not via induction of DNA fragmentation.
|Eur J Med Chem. 2012 Mar;49:55-67. |
|Bakuchiol derivatives as novel and potent cytotoxic agents: a report.[Pubmed: 22245048]|
METHODS AND RESULTS:
A library of 28 compounds comprising of acyl, amino, halo, nitro, styryl and cyclized derivatives of Bakuchiol have been evaluated against a panel of eight human cancer cell lines. Bioevaluation studies have resulted in the identification of potent cytotoxic molecules exhibiting concentration dependent growth inhibition against leukemia cancer cells with best results observed for compounds 17 and 22 exhibiting IC(50) 1.8 and 2.0 μM respectively.
As evident from various biological end-points, inhibition of cell proliferation by inducing G2/M cell cycle arrest, mitochondrial membrane disruption followed by DNA fragmentation and apoptosis is demonstrated.
|Yao Xue Xue Bao. 2010 Apr;45(4):467-70. |
|Vitro antitumor activity and synthesis of the key intermediate of bakuchiol.[Pubmed: 21355211]|
METHODS AND RESULTS:
The in vitro antitumor activity of Bakuchiol was exploited, compared with tamoxifen. The result of biological activities showed that Bakuchiol could inhibit human breast cancer and the IC50 values were 2.89 x 10(-5) mol L(-1) and 8.29 x 10(-3) mol L(-1) against the cells line T-47D and MDA-MB-231 respectively. On the other hand, the key intermediate to synthesize Bakuchiol was obtained by the method of Ireland-Claisen rearrangement.
Comparing with traditional Claisen rearrangement, the reaction conditions are milder and the reaction reagents are safer.
||The barks of Psoralea corylifolia.
||Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)PMID: 29328914
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)PMID: 32004475
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)PMID: 29149595
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)PMID: 29553709
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)PMID: 28005066
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
|Pharmazie. 2014 Jan;69(1):60-3. |
|Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol.[Pubmed: 24601226]|
|Bakuchiol is a promising anti-tumor candidate with resveratrol-like structure. |
The present study aims to evaluate the inhibition potential of Bakuchiol towards UDP-glucuronosyltransferases (UGT) 1A isoforms. An in vitro incubation system using 4-methylumbelliferone (4-MU) glucuronidation was used to evaluate the inhibition capability of Bakuchiol towards UGT1A1, 1A3, 1A6, 1A7, 1A8, 1A9 and 1A10. The glucuronidation of trifluoperazine (TFP) was employed as the probe reaction to determine Bakuchiol's inhibition towards UGT1A4. At 1 microM and 10 microM of Bakuchiol, no or weak inhibition was observed for all the tested UGT1A isoforms. At 100 microM of Bakuchiol, the activity of UGT1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9 and 1A10 was inhibited by -46.2%, 74.7%, 17.8%, 98.7%, 70.4%, 99.2%, 75.8%, and 93.3%, respectively. Further inhibition kinetic behaviour was determined for UGT1A6, 1A8, and 1A10. Both Dixon plot and Lineweaver-Burk plot showed the noncompetitive inhibition of Bakuchiol towards all these three UGT isoforms. The inhibition kinetic parameters (Ki) were calculated to be 5.3, 1.8, and 92.6 microM for UGT1A6, 1A8, and 1A10, respectively. In combination with the in vivo exposure of Bakuchiol, the high possibility of in vivo inhibition of UGT1A6 and 1A8 was predicted. However, relatively low possibility of in vivo inhibition towards UGT1A10 was predicted due to lower in vivo concentration of Bakuchiol than its inhibition parameter (Ki).
All these information will be helpful for the R&D of Bakuchiol as a promising anti-tumor drug.